Category Archives: Business and Investments

Latest From Business and Investments

Recent Developments in Patentability: Prometheus and Myriad

supreme-court

By Joe Allen, President, Allen and Associates Recent Developments in Patentability: Prometheus and Myriad at the 2012 BIO International Convention was a very lively panel discussion on two cases that have set the life science industry on edge. The discussion presented an appropriate diversity of views as experts struggle with how broadly these cases should be interpreted. Briefly, the unanimous decision by the Supreme Court overtuning a decision upholding the Prometheus patents by the Court Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , ,

#Partnering Tips for Next Week’s Big Event

Business Forum

We hope everyone is looking forward to BIO International Convention next week! We wanted to put together a quick list of things to remember and ways to get your questions answered, plus some helpful advice from a Partnering veteran. Read on! Logistical Partnering Tips You will receive an updated meeting schedule via email each night of the conference beginning on Sunday, June 17th. Please be sure to print a schedule each morning (we have printing Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

To Cancel or Not to Cancel

partnering-logo-btn

That is the question! And one that is going to come up quite a bit as we get closer to the BIO International Convention, and so we wanted to address it. You learned all about the Scheduling Process in a previous post, such as what is a delegate’s responsibility, like updating your availability, and what BIO takes care of for you, such as assigning actual space to your meetings. On the note of availability, we Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Tradeshow Speed Dating: Associations Now Piece

tsd-btn

In the April/May issue of Associations Now, writer Jacqui Cook profiled the Biotechnology Industry Organization (BIO) and, appropriately for this post, the BIO One-on-One Partnering System. They give a good synopsis of some of the challenges organizations – and people – face at a typical tradeshow. You’re going there to make contacts, not to mention spending money to do so, and there’s often no real structure, process, or easy ways to discern the value of Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Only a Few Public Biotechs are Profitable, but There are More of Them Today

Of the 294 biotechs trading on public exchanges today, 248 (84%) focus on drug development. Of these 248 in the biopharmaceutical space, 81, or 33% have a drug approved. Only 32 (13%) had both a product on the market and positive net income in 2011. However, this 13% represents a significant jump from the 7.5% with positive net income we calculated for 2009. Note that this comes over a time frame in which a few profitable companies were Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , ,